NCT02446405 2025-02-06
ENZAMET
University of Sydney
Phase 3 Active not recruiting
Clinical Trials
3 trialsNCT04776889 2021-03-02
The Prognosis of Lipid Reprogramming With Rosuvastatin, in Castrated Egyptian Prostate Cancer Patients
National Cancer Institute, Egypt
Phase 4 Completed
NCT00002855 2018-10-31
Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer
M.D. Anderson Cancer Center
Phase 3 Completed